Active Genetics & Molecular Biology Cells, Biochemistry & Physiology

Discovering the mechanism of how trypanosomes epigenetically assemble unconventional kinetochores at centromeres

In plain English

AI plain-English summary

Sleeping sickness parasites build their cell-division machinery without the protein that every other organism uses to anchor it. This matters because the parasites that cause sleeping sickness, Chagas disease, and leishmaniasis threaten nearly a billion people, yet scientists do not understand how they organise their chromosomes during cell division. In most cells, a specialised protein called CENP-A marks the centromere—the spot where the kinetochore, a protein machine, attaches to pull chromosomes apart. Kinetoplastid parasites lack CENP-A entirely. The researcher’s lab has proposed that the parasite uses a chemical mark—methylation—on a different histone protein to block kinetochore binding everywhere except at centromeres, which remain unmarked. This project aims to identify the enzyme that places that mark. If the research succeeds, it will reveal a fundamentally new way that cells specify centromere identity. Because this mechanism is unique to the parasites and absent in humans, the enzyme could become a target for drugs against neglected tropical diseases. This is primarily fundamental science—understanding an unusual epigenetic system—but past discoveries of parasite-specific cell biology have directly led to treatments.

View original technical description
Human African trypanosomiasis, leishmaniasis and Chagas disease endanger almost a billion people, yet their kinetoplastid agents (e.g. Trypanosoma brucei) are still poorly understood. Kinetoplastids lack the centromeric histone CENP-A, so the basis of kinetochore-centromere recognition is unknown. Our lab suggests genome-wide methylation of the histone H3 N-terminus “paints” chromatin to block kinetochore binding, while centromeres remain unmethylated. My project aims to identify the methyltransferase that establishes this pattern in T. brucei. I will perform an in-silico screen, including homology searches, structure prediction, docking, molecular dynamics and protein- language models, to pinpoint candidate enzymes. Hits will be tested by RNAi: loss of the enzyme may mis-localise fluorescent kinetochore proteins, reveal unmethylated H3 epitopes (immunofluorescence) and reduce parasite fitness. Confirmed enzymes will undergo biochemical and structural characterisation (NMR, X-ray/Cryo-EM, activity assays). Uncovering how centromeric identity is specified without CENP-A will illuminate a unique epigenetic mechanism and expose new therapeutic targets against neglected tropical diseases.

View the original record at the funder ↗

Researchers

Sam Forsyth (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Chromatin associated proteins and histone post-translational modification dynamics in the development and immune evasion of the sleeping sickness para
Deciphering mechanisms of epigenetic regulation in Trypanosoma brucei, an evolutionarily distinct human pathogen.
Neddylation underlying Cell Differentiation and Biology in Trypanosomes, evolutionarily distinct human pathogens.
Bridging epigenetics, metabolism and cell cycle in pathogenic trypanosomatids
Mitochondrial biogenesis and function in trypanosomes

Original classification

PhD Studentship (Basic)

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.